SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 115 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96,757,183 | -51.2% | 25,001,856 | -24.9% | 7.02% | -20.7% |
| Q2 2023 | $198,408,507 | +77.2% | 33,290,018 | -2.8% | 8.86% | +103.5% |
| Q1 2023 | $111,961,589 | -17.2% | 34,239,018 | 0.0% | 4.35% | +0.8% |
| Q4 2022 | $135,244,121 | -34.2% | 34,239,018 | 0.0% | 4.32% | -50.1% |
| Q3 2022 | $205,434,000 | -6.7% | 34,239,018 | 0.0% | 8.65% | +4.3% |
| Q2 2022 | $220,158,000 | -22.2% | 34,239,018 | 0.0% | 8.29% | +24.9% |
| Q1 2022 | $282,814,000 | -46.6% | 34,239,018 | 0.0% | 6.64% | -19.0% |
| Q4 2021 | $530,020,000 | -31.3% | 34,239,018 | 0.0% | 8.19% | +1.5% |
| Q3 2021 | $771,063,000 | +14.5% | 34,239,018 | 0.0% | 8.08% | -6.1% |
| Q2 2021 | $673,139,000 | -41.3% | 34,239,018 | 0.0% | 8.60% | -53.2% |
| Q1 2021 | $1,145,980,000 | – | 34,239,018 | – | 18.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |